Delivery Order SPE2DB22D2007-SPE2DB25FJ1WD

Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the drug Kerendia 10 mg Tablet 30s, with a ceiling value of $3,377.11 and a completion date of October 23, 2024. The contract is a firm fixed-price delivery order with no set-aside requirements, indicating open competition. As a large IDC...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of a variety of pharmaceutical products and medical supplies. The contract has a firm fixed price and a ceiling value of $10,128.78, with an ultimate completion date of June 17, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of various pharmaceutical products, including medications for conditions such as diabetes, neurology, and pain management. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $12,778.22 and a performance period through May 30, 2025. AmerisourceBergen Drug Corp holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,508.13 and a performance period through May 2025. It is a firm fixed-price contract for the delivery of various pharmaceutical and medical products, including medications across multiple therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,355.40 and a performance period through May 2, 2025. It is a firm fixed price contract for the delivery of pharmaceutical and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics. The contract is...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,164.36 and a performance period through May 9, 2025. The contract is for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic areas such as diabetes, neurology, and pain management. The contract is not...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of various pharmaceutical products and medical supplies. The contract has a ceiling value of $34,327.25 and is designated as a firm fixed-price delivery order, with an ultimate completion date of June 24, 2025. The contract covers a range of pharmaceutical products, including medications for conditions such as diabetes, neurology,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) to provide a variety of pharmaceutical and medical products to support federal medical procurement needs, particularly for military and veteran healthcare systems. The contract has a ceiling value of $3,190.68 and a period of performance through June 4, 2025. It is a firm fixed-price contract, with no set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed price and a ceiling value of $10,458.67, with a performance period ending on May 6, 2025. The contract is not set aside and provides for the delivery of a range of pharmaceutical and medical products, including medications across various therapeutic areas such as diabetes, neurology,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,488.49, is a firm fixed-price delivery order with an ultimate completion date of April 30, 2025. The contract provides for the delivery of a variety of pharmaceutical products and medical supplies, including medications across multiple therapeutic domains such as diabetes treatments,...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ1WD
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4568376319 ! KERENDIA 10 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $3,441.79 and a period of performance ending on May 29, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp, the prime contractor, is a for-profit organization that has held a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This delivery order contract is part of that broader IDC, enabling AmerisourceBergen to fulfill federal medical supply requirements, particularly for the Defense Health Agency, U.S. Coast Guard, and other government agencies.

Generated 8/27/25, 10:02 AM